文献速递免疫规划传染病防控与疫情报告

2019至2021年北京市水痘流行特征及基因特征分析

[Analysis on the epidemic characteristics and genetic characteristics of varicella in Beijing from 2019 to 2021].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2022-01-01

分析2019至2021年北京市水痘报告发病率、季节高峰、学校暴发中免疫史构成及突破病例特征,并对水痘样本进行核酸检测与ORF22、ORF38序列分析。三年报告发病率分别为63.8/10万、32.2/10万、38.6/10万,2020年第一个流行高峰几乎消失;测序株以clade 2型为主(307/311,98.72%)。

要点

  • 2019至2021年北京市水痘报告发病率分别为63.8/10万、32.2/10万、38.6/10万。
  • 学校暴发水痘病例中无免疫史、1剂次、2剂次免疫史学生构成比分别为33.12%、44.79%、22.08%。
  • 311株测序株中clade 2型307株(98.72%)、clade 3型1株(0.32%)、clade 5型3株(0.96%)。

核心结论

  • 2019至2021年北京市水痘每年有两个发病高峰(5月和11月),但2020年第一个流行高峰几乎消失。
  • 水痘突破病例主要人群为6~14岁儿童(523/755,69.27%)。
  • 311株测序株以clade 2型为主(307株,98.72%),ORF22基因片段与各基因型参考株核苷酸同源性为99.4%~100%,氨基酸同源性为99.4%~100%。

研究设计与样本

  • 对2019至2021年北京市水痘报告发病率及学校暴发疫情进行流行病学分析。
  • 采集1 089份水痘病例标本进行核酸检测,选取417份阳性标本测序,311份获得ORF22和ORF38序列。

主要发现

  • 2019至2021年水痘年均报告发病率分别为63.8/10万、32.2/10万、38.6/10万。
  • 学校暴发水痘病例中无疫苗免疫史、1剂次免疫史、2剂次免疫史学生构成比分别为33.12%、44.79%、22.08%。
  • 无免疫史、1剂次免疫史、2剂次免疫史3组病例的中重度出疹比例分别为55.32%、39.06%、29.96%(P<0.001)。
  • 1 089份标本中837份(76.86%)水痘核酸检测阳性,均为野毒株。
  • 311株测序株中307株为clade 2型(98.72%)、1株clade 3型(0.32%)、3株clade 5型(0.96%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The reported incidence of varicella in Beijing from 2019 to 2021 were 63.8/100 000, 32.2/100 000 and 38.6/100 000, respectively. There were two VZV epidemics in Beijing each year, one peaked in May and the other in November. However, the first VZV epidemic almost disappeared in 2020. Among the cases involved in the varicella outbreaks in school, the proportion of the students with no history of vaccine immunization, 1 dose of immunization and 2 doses of immunization were 33.12%, 44.79% and 22.08%, respectively. The major body of VZV breakthrough cases was children aged 6-14 years (523/755, 69.27%). The proportion of moderate- or severe-rash were 55.32%, 39.06%, 29.96% in the three groups of cases with no immunization history, 1 dose of immunization and 2 doses of immunization, respectively (P<0.001). A total of 1 089 varicella samples were collected, and 837 (76.86%) were confirmed to be PCR-positive for VZV and were identified as VZV wild strains. 311 VZV strains were sequenced successfully, and 307 strains were clade 2 (98.72%), 1 clade 3 (0.32%) and 3 Clade 5 (0.96%). Compared with the representative strains, the nucleotide similarities of ORF22 fragments were between 99.4% and 100%, and amino acid similarities were between 99.4% and 100%. 2019—2021年北京地区水痘年均报告发病率分别为63.8/10万、32.2/10万、38.6/10万。水痘每年有两个发病高峰(5月和11月),但是2020年第一个流行高峰几乎消失。在学校暴发疫情的水痘病例中,无疫苗免疫史、1剂次疫苗免疫史、2剂次疫苗免疫史学生所占构成比分别为33.12%、44.79%、22.08%。水痘突破病例主要人群为6~14岁儿童(523/755,69.27%),无免疫史,有1剂次免疫史和2剂次免疫史3个病例组的中重度出疹比例分别为55.32%、39.06%、29.96%(P<0.001)。采集的1 089份水痘病例标本中837份为水痘核酸检测阳性,均为野毒株,选取417份阳性标本进行测序,311份阳性样本均获得了ORF22和ORF38序列,其中307株为clade 2型(98.72%)、1株clade 3型(0.32%)和3株clade 5型(0.96%),311株毒株ORF22基因片段与各基因型参考株的核苷酸同源性为99.4%~100%,氨基酸同源性为99.4%~100%。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li AH, Zhao D, Wen XJ, et al. [Analysis on the epidemic characteristics and genetic characteristics of varicella in Beijing from 2019 to 2021]. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 35922241. doi:10.3760/cma.j.cn112150-20220514-00479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。